UPDATED
Current
Trends in RA
Welcome to our exclusive blog forum for rheumatology experts addressing some of the most important trends concerning RA today. This updated page includes new blogs from rheumatology experts from around the world sharing insights from ACR Convergence 2020 presentations, as well previous postings.
Review of ACR Guideline Updates
A long-awaited update to the ACR Guidelines for RA was presented at the ACR Convergence 2020 this month. Since the last update in 2015, the field has seen both…
ACR Round-Up Panel Discussion
Following the ACR Convergence Meeting 2020, Professor Bruce Kirkham caught up with Professor Robert Moots and Dr. Zoe Cole to share some of their highlights.
The Challenge of Comorbid Conditions on Patient Management in RA: Updates from ACR
Unsurprisingly, COVID-19 held centre stage at this year’s ACR Convergence 2020, just as it has across many facets of our lives and clinical practices. While it did …
Emerging Data and Perspectives on COVID-19: Updates from ACR Convergence 2020
This year has brought unprecedented change that none of us could have ever imagined. Italy, my home country, was hit especially hard during this pandemic leading to…
Recap and Perspectives of “The Great Debate: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After MTX Failure In RA”
As new therapies are approved for RA, we must consider where they best fit into the overall treatment strategy. Treatments with the MOA of JAK inhibition (JAKi)…
PROs and the Virtual Setting: Is There a Gap in Patient Care During the Pandemic?
When the pandemic first hit my home country of Italy, everything stopped. Trains quit running, curfews were set, and we were told to stay home. While this was, of course…
More Than Just RA: The Impact of Comorbidities on Patients Living with RA
For rheumatologists managing patients with RA, it’s natural to focus most closely on RA and its direct impacts. However, 60% of patients with RA have 3 or more comorbidities…
COVID-19 and the Rheumatologist in the “New” Pandemic World
Patients living with inflammatory conditions have been especially hard hit by the COVID-19 pandemic. Setting aside their risk of contracting the virus, they are also…
Cytokines, the Pawns in the Game of RA Chess
Like a complex game of chess, RA is driven by numerous players, each with their own unique roles. Pawns, the most numerous pieces in the game, can be precisely…
Top 3 Most Important Outcomes for Patients with RA
As we all look forward to next week’s virtual ACR Convergence 2020, it is a good time to reflect on the key topics in the field of rheumatology, especially in the era of…
Benefits of the Treat-to-Target Approach in RA
Thanks to significant advances in the care and treatment of patients with rheumatoid arthritis, many agree that the target of treatment should be to help patients…
Discover what fuels the
JAK-STAT pathway.
The latest research in the
JAK-STAT pathway is emerging now.
Visit Learnjakstat.com